Frequency of Metabolic Syndrome in Down Syndrome Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00864461
Recruitment Status : Completed
First Posted : March 18, 2009
Last Update Posted : May 5, 2017
Information provided by (Responsible Party):

Brief Summary:
The aim of this study is to assess the frequency of metabolic syndrome in Down syndrome patients because the prevalence of diabetes mellitus and obesity is higher in individuals with Down syndrome than in the general population.

Condition or disease
Metabolic Syndrome X Down Syndrome

Study Type : Observational
Actual Enrollment : 96 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Prevalence of Metabolic Syndrome in Down Syndrome Patients
Actual Study Start Date : September 1, 2009
Primary Completion Date : December 21, 2009
Study Completion Date : March 31, 2010

Patients with clinical and cytogenetics diagnosis of Down syndrome, between 7 - 24 years old.
Siblings of the same gender of the case, between 7-24 years old.

Primary Outcome Measures :
  1. To asses the frequency of the metabolic syndrome among Down syndrome patients. Metabolic syndrome was defined by Adult Treatment Panel III criteria modified by Halley-Castillo. [ Time Frame: One year ]

Secondary Outcome Measures :
  1. Evaluate the insulin resistance and insulin sensitivity using the HOMA and QUICKY methods. [ Time Frame: One year ]

Biospecimen Retention:   Samples With DNA
Whole blood

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   7 Years to 24 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Community sample

Inclusion Criteria:

  • Clinical diagnosis of Down syndrome

Exclusion Criteria:

  • History of congenital cardiac defects requiring open-heart surgery
  • History of gastroenterologic anomalies requiring bowel resection and/or ongoing medical intervention
  • History of leukemia or other cancer
  • History of hypothyroidism requiring thyroid hormone replacement

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00864461

School of Medicine, University of Guanajuato
Leon, Guanajuato, Mexico, 37320
Sponsors and Collaborators
Universidad de Guanajuato

Responsible Party: ALEJANDRO ERNESTO MACIAS HERNANDEZ, MD, Universidad de Guanajuato Identifier: NCT00864461     History of Changes
Other Study ID Numbers: 249-08
First Posted: March 18, 2009    Key Record Dates
Last Update Posted: May 5, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by ALEJANDRO ERNESTO MACIAS HERNANDEZ, Universidad de Guanajuato:
Down syndrome
Metabolic syndrome X
Insulin resistance

Additional relevant MeSH terms:
Metabolic Syndrome X
Down Syndrome
Pathologic Processes
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Abnormalities, Multiple
Congenital Abnormalities
Chromosome Disorders
Genetic Diseases, Inborn